Both in Pharmaceuticals
Corcept Therapeutics vs Cytokinetics
Over the past year CORT returned +10.5% and CYTK returned +3.8%; their daily moves had a correlation of 0.11.
CORT +10.5% CYTK +3.8%Growth of $1, one year, split-adjusted
| Metric | CORT | CYTK |
|---|---|---|
| Price | $81.93 | $62.31 |
| Market cap | $8.86B | $8.66B |
| Today | +1.83% | +0.45% |
| 1 month | −32.9% | −0.6% |
| 6 months | +59.6% | −19.2% |
| Year to date | +135.4% | −1.9% |
| 1 year | +11.5% | −2.0% |
| Revenue growth (YoY) | +31.7% | −57.1% |
| Gross margin | 98.4% | 90.5% |
| Net margin | 16.8% | −694.4% |
| P/E (TTM) | 162.5× | — |
| Price / sales | 10.7× | 128.0× |
| Net cash | $308.2M | $18.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 31.7% |
| Short % of float | 9.0% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).